NCT01793948View on ClinicalTrials.gov

Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 16, 2013

Primary Completion Date

January 9, 2018

Study Completion Date

January 9, 2018

Conditions
Breast CancerObesity
Interventions
DRUG

metformin hydrochloride

Given PO

OTHER

placebo

Given PO

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

46202

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Anna Maria Storniolo

OTHER

NCT01793948 - Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer | Biotech Hunter | Biotech Hunter